Vimarsana
Biggest News Aggregation in the World

Trial Endpoints News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Trial Endpoints. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Trial Endpoints Today - Breaking & Trending Today

National Organization for Rare Disorders Launches Education Series to Advance Patient Involvement in Rare Disease Drug Development - Vimarsana News

National Organization for Rare Disorders Launches Education Series to Advance Patient Involvement in Rare Disease Drug Development

Published: October 16, 2023

/PRNewswire/ -- Today, the National Organization for Rare Disorders (NORD®) launched a new education series in English and Spanish titled, "Rare Disease Drug...

Source: prnewswire.com
Related Topics:
United StatesNoord HollandCollin HovingaRobertm CaliffPeterl SaltonstallStakeholder Roles In Drug DevelopmentCritical Path InitiativeDrug AdministrationRare Disease Drug DevelopmentNational Organization For Rare DisordersCritical Path InstituteRare Disease Drug Development SeriesDrug DevelopmentCritical PathNational OrganizationRare DisordersDisease Drug DevelopmentWhat PatientsAdvocates NeedRebecca AuneEducation ProgramsHistory StudiesExperience DataSmall PopulationsTrial Endpoints
Lessons Learned in Other Cancers and Suggested Endpoints in Future Trials - Vimarsana News

Lessons Learned in Other Cancers and Suggested Endpoints in Future Trials

Published: April 12, 2023

Key opinion leaders take time to review how immune checkpoint inhibitors have transformed outcomes in rectal cancer and non-cutaneous squamous cell cancers and consider how to better structure clinical trial endpoints in CSCC.

Source: onclive.com
Related Topics:
Data UpdatesResectable Cutaneous Squamous Cell CarcinomaSuggested EndpointsFuture TrialsCutaneous Squamous Cell CarcinomaSkin CancerSquamous Cell Skin CancerTrio TherapyImmune Checkpoint InhibitorsNeoadjuvant TherapyNeoadjuvant TreatmentRectal CancerTrial EndpointsClinical Trial EndpointsClinical Trials